Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Latest News about RHHBY

Recent news which mentions RHHBY

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Why MacroGenics Soared Nearly 9% Higher Today
Tickers MGNX RHHBY
Tags Market News MGNX RHHBY
From Motley Fool
The Daily Biotech Pulse: ProQR-Lilly R&D Partnership, Sanofi's Pemphigus Trial Disappointment, Humanigen's COVID-19 Drug Denied Emergency Use Authorization
Tickers ABSI ABT AZN BIVI
Tags IBB IDYA KDMN
From Benzinga
Roche Beefs Up PCR-Test Portfolio With TIB Molbiol Acquisition
Tickers RHHBF RHHBY RHHVF
Tags Market News Health Care M&A
From Benzinga
2 Stocks I Bought Last Week
Tickers AZN JYNT NVAX PIRS
Tags Market News PIRS JYNT
From Motley Fool
MacroGenics' Cancer Drug Margenza Flops On Overall Survival Analysis
Tickers MGNX RHHBF RHHBY RHHVF
Tags News Briefs breast cancer
From Benzinga
7 Meme Stocks You Should Keep a Close Eye on for Real Potential
Tickers AMZN FORD GM HOOD
Tags QUAD FORD AMZN
From InvestorPlace
Why Adaptimmune Therapeutics Stock Is Bolting Higher Today
Tickers ADAP RHHBY
Tags RHHBY ADAP Market News
From Motley Fool
Adaptimmune Stock Moves Higher On Cancer Deal With Genentech
Tickers ADAP RHHBF RHHBY RHHVF
Tags Briefs News Allogeneic Cell Therapy
From Benzinga
Roche's Spark Therapeutics, NeuExcell Join Forces To Develop Huntington's Disease Gene Therapy
Tickers RHHBF RHHBY RHHVF
Tags General RHHBF Briefs
From Benzinga
Is Exelixis Stock a Buy?
Tickers EXEL RHHBY
Tags EXEL RHHBY BAYR/Y
From Motley Fool
COVID 19 Stocks -- Vaccines, Diagnostics, or Treatments?
Tickers ABT CDNA GH GILD
Tags Market News CDNA GILD
From Motley Fool
Attention Biotech Investors: Mark Your Calendar For September PDUFA Dates
Tickers ABBV ASND BGNE BIIB
Tags News SNY Top Stories
From Benzinga
See Why AC Immune Stock Is Trading Higher After Data From Alzheimer's Candidate
Tickers ACIU RHHBF RHHBY RHHVF
Tags Alzheimer's disease Health Care Biotech
From Benzinga
After Bladder Cancer, Roche Pulls Breast Cancer Indication For Tecentriq In US
Tickers RHHBF RHHBY RHHVF
Tags RHHBF General breast cancer
From Benzinga
Which Biotech Stock Will Shock the Market in 2022?
Tickers AXSM AZN NDAQ NVAX
Tags NDAQ NVAX RHHBY
From Motley Fool
Shape Therapeutics, Roche Form $3B RNA Editing Collaboration
Tickers RHHBF RHHBY RHHVF
Tags RHHBY RHHVF Health Care
From Benzinga
Why Shares of Global Blood Therapeutics Are Soaring Today
Tickers CRSP GBT RHHBY VRTX
Tags VRTX RHHBY CRSP
From Motley Fool
UK Approves Regeneron - Roche's COVID-19 Antibody Cocktail
Tickers REGN RHHBF RHHBY RHHVF
Tags REGN General RHHBF
From Benzinga
Could Biogen Acquire Axsome Therapeutics?
Tickers AXSM BIIB LLY RHHBY
Tags AXSM RHHBY LLY
From Motley Fool
Roche's Arthritis Drug, Used As COVID-19 Treatment, Faces Supply Shortage
Tickers RHHBF RHHBY RHHVF SNY
Tags General RHHBF News
From Benzinga
AstraZeneca, Daiichi Sankyo's Enhertu Shows Improved PFS Over Roche's Kadcyla In Breast Cancer
Tickers AZN DSKYF DSNKY RHHBF
Tags RHHBY AZN RHHVF
From Benzinga
Genentech's Polivy Plus R-CHP Shows Prolonged Survival In Newly Diagnosed DLBCL Patients
Tickers RHHBF RHHBY RHHVF
Tags Health Care Briefs Biotech
From Benzinga
Here Are the Winners of Cowen's Big Pharma R&D Showdown
Tickers ABBV COWN LLY MRK
Tags Market News MRK NVS
From Motley Fool
These OTC Securities Had the Most Trading Activity in July
Tickers BDRBF CLXPF ETHE FNMA
Tags Partner Content FNMA General
From Benzinga
Illumina Stock Will Be Unstoppable Once the Grail Acquisition Gets Approved
Tickers EXAS GH ILMN NTRA
Tags NTRA Stocks to Buy NVTA
From InvestorPlace
Pfizer's CEO Wants to Go Shopping: 3 Potential Companies on His Radar
Tickers AUPH AVIR AZN BPMC
Tags BPMC AVIR RHHBY
From Motley Fool
Moderna Vs. BioNTech: How Do These High-Flying COVID-19 Vaccine Stocks Compare?
Tickers BNTX MRNA PFE RHHBY
Tags Benzinga Biotech Health Care
From Benzinga
Billionaire Masayoshi Son's SoftBank Claims $5B Stake In Roche: Bloomberg
Tickers ABCL PACB RHHBF RHHBY
Tags SFTBF Movers General
From Benzinga
This High-Risk, High-Reward Biotech Could Make COVID Less Deadly -- and Make Investors Money
Tickers AVIR GILD MRK RHHBY
Tags RHHBY GILD AVIR
From Motley Fool
The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business
Tickers ABSI ACET ADCT ADVM
Tags COGT IMGO ANGN
From Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.